PM R, 2010 · DOI: 10.1016/j.pmrj.2010.10.013 · Published: December 1, 2010
Low-level laser therapy (LLLT), also known as photobiomodulation, uses low-powered lasers to stimulate a biological response in cells, without generating heat, sound or vibration. Mitochondria within cells are believed to be the primary targets of this light, leading to increased production of ATP, reactive oxygen species, intracellular calcium, and nitric oxide release. This process can activate transcription factors, resulting in the expression of protective, anti-apoptotic, anti-oxidant, and pro-proliferation genes.
LLLT can be used to improve neurological deficits and promote neurogenesis after stroke, potentially leading to better functional outcomes.
Transcranial LLLT may reduce long-term neurological deficits and decrease lesion size following traumatic brain injury, offering a non-invasive treatment option.
LLLT can enhance the regenerative process of peripheral nerves after injury, potentially improving motor function and functional recovery.